Neurovalens
Latest round
- Series A
Last raised
- Jan 2019
Total raised
- $7.6M
Investors
- 6
About Neurovalens
Founded in 2013 and based in Belfast, UK, Neurovalens Limited operates as a medical technology company. The company was founded by its CEO, Jason McKeown, and Paul D. McGeoch. Neurovalens develops medical devices, mainly non-invasive neurostimulation products, to treat chronic insomnia and generalized anxiety disorder.
Who invested in Neurovalens
6 investors across 2 rounds
See all investors in Neurovalens
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurovalens
Who invested in Neurovalens?
Neurovalens has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurovalens raised?
Neurovalens has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurovalens last raise money?
Neurovalens's most recent round on record is a Series A, in Jan 2019.
What does Neurovalens do?
Founded in 2013 and based in Belfast, UK, Neurovalens Limited operates as a medical technology company.
Where is Neurovalens headquartered?
Neurovalens is headquartered in Belfast, UK.
Which VCs invest in companies like Neurovalens?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Neurovalens's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Neurovalens? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.